Martin Shkreli, Chief Executive Officer, 10% Owner at KALOBIOS PHARMACEUTICALS INC (KBIO), bought 5,000 shares at $38.15 ($191K) on 2015-11-24, disclosed to the SEC on 2015-11-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KBIO | BUY | 2015-11-19 | $889K | — | Filing → |
| KBIO | BUY | 2015-11-18 | $1.6M | — | Filing → |
| RTRX | SELL | 2014-11-24 | $10.4M | — | Filing → |